Adverse events744

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 744

Type	Event	Organ system	Group	Affected	At risk	Events
other	Diarrhoea	Gastrointestinal disorders	RSV Season 1: Clesrovimab 105 mg	139	2,409	155
other	Diarrhoea	Gastrointestinal disorders	RSV Season 1: Placebo	77	1,202	91
other	Diarrhoea	Gastrointestinal disorders	RSV Season 2: Clesrovimab 105 mg	0	0	0
other	Diarrhoea	Gastrointestinal disorders	RSV Season 2: Placebo	0	0	0
other	Injection site pain	General disorders	RSV Season 1: Clesrovimab 105 mg	156	2,409	159
other	Injection site pain	General disorders	RSV Season 1: Placebo	96	1,202	97
other	Injection site pain	General disorders	RSV Season 2: Clesrovimab 105 mg	0	0	0
other	Injection site pain	General disorders	RSV Season 2: Placebo	0	0	0
other	Nasopharyngitis	Infections and infestations	RSV Season 1: Clesrovimab 105 mg	139	2,409	158
other	Nasopharyngitis	Infections and infestations	RSV Season 1: Placebo	78	1,202	89
other	Nasopharyngitis	Infections and infestations	RSV Season 2: Clesrovimab 105 mg	0	0	0
other	Nasopharyngitis	Infections and infestations	RSV Season 2: Placebo	0	0	0
other	Upper respiratory tract infection	Infections and infestations	RSV Season 1: Clesrovimab 105 mg	351	2,409	415
other	Upper respiratory tract infection	Infections and infestations	RSV Season 1: Placebo	189	1,202	212
other	Upper respiratory tract infection	Infections and infestations	RSV Season 2: Clesrovimab 105 mg	0	0	0
other	Upper respiratory tract infection	Infections and infestations	RSV Season 2: Placebo	0	0	0
other	Body temperature increased	Investigations	RSV Season 1: Clesrovimab 105 mg	215	2,409	253
other	Body temperature increased	Investigations	RSV Season 1: Placebo	108	1,202	123
other	Body temperature increased	Investigations	RSV Season 2: Clesrovimab 105 mg	0	0	0
other	Body temperature increased	Investigations	RSV Season 2: Placebo	0	0	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04767373/events

API reference For AI assistants

Adverse events744

Sources 3

Read this list from software.